排序方式: 共有96条查询结果,搜索用时 15 毫秒
81.
82.
目的:基于中医传承计算平台(V3.0),挖掘宋立群教授治疗糖尿病肾病的用药规律及辨治经验,总结其学术思想。方法:收集肾病门诊2016年1月—2020年1月宋立群教授治疗DKD首诊处方,建立医案数据库,运用频次统计分析,相关规则分析,聚类分析等数据挖掘方法,探讨导师组方规律和辨治经验。结果:202张处方涉及用药180味,总使用频次3375次,常用药物31味,药物以补虚药为主,其次为收涩药、利水渗湿药;四气统计温性药最多,平性药次之;药味使用数最多的是甘味药和苦味药;归经统计肾经、肝经、脾经的药物最常用;常用药物组合138个,聚类分析结合临床经验得到常用特色药对5组。结论:宋立群教授治疗DKD肝脾肾同调,补虚扶正并泻实祛邪,兼以解郁、祛痰、化瘀,以期为今后的中医肾病临床提供参考。 相似文献
83.
84.
目的:观察五子衍宗丸干预肾病综合征SD大鼠对生精细胞T型Ca2+通道及顶体酶PPEF1活性的影响及作用机制。方法:按照随机数字表法将70只SD大鼠分为空白组(蒸馏水1 mL灌胃)、肾病模型组(蒸馏水1 mL灌胃)、肾病模型+雷公藤多苷组(雷公藤多苷0.04 mg·kg-1·d-1灌胃)、肾病模型+五子衍宗丸组(五子衍宗丸1.07 g·kg-1·d-1灌胃)、肾病模型+雷公藤多苷+低剂量五子衍宗丸组(雷公藤多苷0.04 mg·kg-1·d-1与五子衍宗丸0.54 g·kg-1·d-1同时灌胃)、肾病模型+雷公藤多苷+中剂量五子衍宗丸组(雷公藤多苷0.04 mg·kg-1·d-1与五子衍宗丸1.07 g·kg-1·d-1同时灌胃)、肾病模型+雷公藤多苷+高剂量五子衍宗丸组(雷公藤多苷0.04 mg·kg 相似文献
85.
目的 观察维替泊芬光动力疗法(photodynamic therapy,PDT)对息肉状脉络膜血管病变(polypoidal choroidal vasculopathy,PCV)的1年治疗效果.方法 9例(10只眼)经眼底彩照、荧光素眼底血管造影(fundus fluorescein angiography,FFA)和吲哚青绿血管造影(indocyanine green angiography,ICGA)确诊的PCV患者,进行常规的PDT治疗,治疗后随访第2周、1月、3月、6月、1年,观察治疗前后的视力、眼底彩照、FFA和(或)ICGA.结果 PDT治疗后1年视力提高3只眼,视力稳定6只眼,1只眼PDT治疗后出血吸收第2月复发黄斑区出血视力下降;1只眼治疗后第2周出现严重视网膜下出血,随访后渐吸收,其余患眼底出血、渗出均吸收消失.第3个月造影检查渗漏停止7只眼,3只眼轻微渗漏,末次随访3只眼仍轻微渗漏.PDT治疗过程无一例出现严重全身并发症.结论 PDT是一种安全有效的PCV治疗方法,可以短期内减轻或封闭异常血管的渗漏,促进出血、渗出吸收,稳定或提高患者视力,个别患者治疗后出现严重网膜下出血能自行吸收.Abstract: Objective To observe prospectively one-year's effect of photodynamic therapy (PDT)with verteporfin in polypoidal choroidal vasculopathy (PCV). Methods Nine patients (10 eyes) diagnosed as PCV according to fundus color, fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) were performed PDT. Visual acuity, Fundus appearance, FFA and/or ICGA were compared before PDT, and then at 2 weeks, 1 month, 3 months, 6 months and 12 months afier PDT.Results One year after the PDT, visual acuity was improved in 3 eyes and stabilized in 6 eyes. Visual acuity in one eye decreased again because of recurred macular bleeding. Massive subretinal hemorthage in one eye appeared two weeks after PDT and absorbed during the period of follow-up. The bleeding and exudates in the last 8 eyes were absorbed during the follow-up. At the 3 months, FFA and/or ICGA showed no Ieakage in 7 eyes, slight leakage in 3 eyes and still leakage at the final follow-up. No systemic adverse effect was found during and after PDT. Conclusions PDT offers an effective and safe way of treating PCV. PDT may relieve or stop vascular leakage, promote the elimination of the retinal hemorrhage and exudates, improve or stable the visual acuity. Massive retinal hemorrhage after PDT appears and absorbs in individual patients. 相似文献
86.
卵磷脂络合碘治疗玻璃体切割术后玻璃体混浊临床分析 总被引:1,自引:0,他引:1
Objective To Investigate the efficacy of Jolethin in treating vitreous inflammafive opacity after vitrectomy.Methods Forty-four consecutive cases(44 eyes)with vitreous hemorrhage received standard three-port vitrectomy and laser photoeoagulation.After surgery,all the patients were randomly divided into two groups.Jolethin were applied in group A,and only corticosteroid was administrated in group B.Postoperative follow-up was scheduled in 2,4 and 8 weeks,and the grade of vitreous opacity was recorded.Results In 2,4 and 8 weeks after vitrectomy,vitreous opacity was significantly improved in the eyes in group A.The numbers of eyes with grade 1 of vitreous opacity was more than group B statistically,and those with grade 2 and 3 of vitreous opacity were less than group B in various postoperative week(P<0.05).Conclusions Jolethin can effectively accelerate the absorption of vitreous opacity after vitrectomy. 相似文献
87.
88.
采用主观和客观睡眠质量评价方法,对脑电联合肌电生物反馈治疗职业中毒恢复期失眠症患者的临床疗效和安全性进行为期8周的临床研究。疗程结束后,两组患者主观睡眠质量情况均较治疗前显著改善,且观察组的疗效优于对照组(P0.05);两组客观指标亦较治疗前有所改善,但差异无统计学意义(P0.05)。提示脑电联合肌电生物反馈对改善职业中毒恢复期患者主观睡眠质量有一定疗效,可供临床医生选择。 相似文献
89.
目的 评价地西他滨联合小剂量阿糖胞苷治疗老年急性髓细胞白血病的疗效及安全性.方法 选取我院收治的60例老年急性髓系白血病(acute myelogenous leukemia,AML)患者,分为对照组和观察组.对照组患者使用低剂量阿糖胞苷治疗,观察组患者使用地西他滨联合低剂量阿糖胞苷治疗,对比两组患者的临床疗效和不良反应发生情况.结果 观察组患者总缓解率为85%,对照组患者总缓解率为57.5%,两者差异具有统计学意义(P<0.05).治疗后观察组发生出血、感染、心脏毒性等不良反应率低于观察组,差异有统计学意义(P<0.05).结论 地西他滨联合低剂量阿糖胞苷化疗方案运用于老年急性髓系白血病的临床效果确切,安全性较好,值得临床推广. 相似文献
90.
目的 评价地西他滨联合小剂量阿糖胞苷治疗老年急性髓细胞白血病的疗效及安全性.方法 选取我院收治的60例老年急性髓系白血病(acute myelogenous leukemia,AML)患者,分为对照组和观察组.对照组患者使用低剂量阿糖胞苷治疗,观察组患者使用地西他滨联合低剂量阿糖胞苷治疗,对比两组患者的临床疗效和不良反应发生情况.结果 观察组患者总缓解率为85%,对照组患者总缓解率为57.5%,两者差异具有统计学意义(P<0.05).治疗后观察组发生出血、感染、心脏毒性等不良反应率低于观察组,差异有统计学意义(P<0.05).结论 地西他滨联合低剂量阿糖胞苷化疗方案运用于老年急性髓系白血病的临床效果确切,安全性较好,值得临床推广. 相似文献